- recruiting
Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
This study looks at how well a device called the NeoChord Artificial Chordae System works for people with a heart condition called mitral valve disease. It tracks patients for five years after they've had the treatment, to see how they're doing in the long term.
Germany · Greece · Switzerland - recruitingNA
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
This study looks at a new device, the Carillon Mitral Contour System, for people with heart failure caused by a leaky heart valve. It aims to see if the device is safe and helps improve their condition, comparing it to usual care without the device.
United States · Canada · France - not yet recruiting
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
This study looks at a new way to treat problems with the heart's aortic valve, called TAVI, using the Trilogy Heart Valve System. It helps doctors understand how well this treatment works for people with a narrowed or leaky aortic valve. It's for patients aged 18 and over.
Germany - recruiting
London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound
This study uses heart scans in local communities to find heart valve problems and heart weakness in people over 65, especially in diverse groups. The goal is to train local staff to do these quick scans, helping people get treatment sooner and reduce emergency hospital visits.
United Kingdom - enrolling by invitationNA
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
This study is looking at a new heart valve replacement called Navitor TAVI. It wants to see if it's safe and works well for people with a common heart problem called severe aortic stenosis, which narrows a main heart valve. It's for adults at different surgical risks.
United States · Australia · Belgium - active not recruitingNA
TRISCEND II Pivotal Trial
This study is testing a new device called the Edwards EVOQUE system for people with severe tricuspid valve disease. It compares the device plus regular care to regular care alone, aiming to see if the device is safe and effective.
United States · Germany - active not recruitingNA
2019-06 TRISCEND Study
This study looks at a new heart valve replacement called Edwards EVOQUE for people with a leaky tricuspid valve. It aims to see how safe and well this new treatment works for those whose current medicines aren't enough to help their symptoms.
United States · Canada · France - active not recruitingNA
Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
This study is testing a new AI-powered stethoscope to see if it can help doctors in local clinics find heart problems like heart failure earlier. The aim is to improve heart health and reduce emergency hospital visits for these conditions.
United Kingdom - recruiting
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
This study looks at a new treatment called the EVOQUE system for a heart condition called tricuspid valve regurgitation. It's for people in Europe whose heart valve leaks. Doctors want to see how safe and effective this treatment is in real-life settings for up to 500 patients.
Germany · Greece · Italy